With the introduction of enzymatic Pre-Splitting technology, fatty acid producers can expect up to 30 percent energy savings, achieve a higher degree of splitting, increase capacity and save up to 30% water usage in the thermal fat splitting process. 

With the introduction of enzymatic Pre-Splitting technology, fatty acid producers can expect up to 30% energy savings, achieve a higher degree of splitting, increase capacity and save up to 30% water usage in the thermal fat splitting process. 

COPENHAGEN, Denmark – June 29, 2023. For fatty acid producers, achieving a 98% degree of splitting is one of the most important goals. But in the process of reaching their efficiency goal, fatty acid producers have to balance challenges such as energy costs, water usage and yield maximization. With its latest biosolution, Lipura® Split, Novozymes uses enzymatic Pre-Splitting Technology to address those challenges with an easy-to-implement process that increases efficiency, sustainability, and profitability with little or no capital expense.

“Oleochemical producers are faced with changing market demands. Within fatty acid production, companies need to explore ways to stay agile, maximize the value of their feedstock and make their production more profitable and sustainable. We are excited to be the first to offer a biosolutions for pre-splitting solution at-scale to fatty acid producers, that can deliver more flexibility and improved economics,” says Hans Ole Klingenberg, Vice President, Agriculture & Industrial Biosolutions at Novozymes.

Industry standard is efficient but throughput is slow  
Fatty acid is a building block for a wide range of industry products from lubricants to foods. In the first phase of producing fatty acid – the thermal fat splitting process – fats and vegetable oils (triglycerides) are converted into fatty acids and glycerol. This happens in a high-pressure, high temperature splitting tower. 

Although the standard process for thermal fat splitting is generally effective, throughput is slow, and a great deal of energy is needed. Conversion of triglycerides happens in three stages. The first stage is slow as water and fat mix. It is only in the second stage that most of the fat is split. By pre-splitting with Lipura® Split, fatty acid producers can accelerate the rate of reaction in the first stage and increase production capacity by up to 20%. 
 

Novozymes’ Lipura® Split video screenshot


To watch a video illustration and for more details about Novozymes’ Lipura® Split, visit Novozymes’ global web page here. 

Increased efficiency and less energy and water needed 
Pre-splitting is a supplemental process that significantly increases efficiency in thermal splitting. Novozymes’ Lipura® Split – an enzyme biocatalyst – and water are added to any oil and fat feedstock in an existing stir tank and agitated prior to introducing the mix into a splitting tower. 

The enzymatic pre-splitting reaction significantly reduces and, in some cases, even eliminates the initial stage of the thermal splitting reaction, thereby making the process more efficient by reducing the amount of energy required.

“Ultimately, our goal is to help fatty acid producers achieve a higher level of splitting and increase their capacity while reducing their use of energy and water. Our latest biosolution, Lipura® Split, makes this achievable at a minimal cost,” says Hans Ole Klingenberg, Vice President, Agriculture & Industrial Biosolutions at Novozymes.

Lina Danstrup

Lina Danstrup

Head of External Communicationlind@novozymes.com+45 30 77 05 52

Related articles

Novonesis HQ in Lyngby, Denmark
01.02.24 | 8 minute read

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.
Novonesis office
29.01.24 | 6 minute read

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries. Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet.
Novonesis
13.12.23 | 8 minute read

Novozymes and Chr. Hansen announce name of future combined company; Novonesis

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in biological sciences and technology will offer solutions to solve some of the biggest challenges facing humanity.